$FPRX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in FIVE PRIME THERAPEUTICS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in FIVE PRIME THERAPEUTICS, INC.. Get notifications about new insider transactions in FIVE PRIME THERAPEUTICS, INC. for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 12 2016 | FPRX | FIVE PRIME THERAPE ... | Knickerbocker Aron Marc | Chief Operating Off ... | Grant | A | 0.00 | 10,000 | 0 | 185,889 | 175.9 K to 185.9 K (+5.69 %) |
| Sep 02 2016 | FPRX | FIVE PRIME THERAPE ... | RINGO WILLIAM R | Director | Option Exercise | S | 44.20 | 500 | 22,100 | 24,000 | |
| Sep 02 2016 | FPRX | FIVE PRIME THERAPE ... | RINGO WILLIAM R | Director | Sell | S | 44.20 | 500 | 22,100 | 0 | 500 to 0 (-100.00 %) |
| Sep 02 2016 | FPRX | FIVE PRIME THERAPE ... | RINGO WILLIAM R | Director | Buy | M | 11.65 | 500 | 5,825 | 500 | 0 to 500 |
| Sep 01 2016 | FPRX | FIVE PRIME THERAPE ... | Sikorski Robert Steven | SVP and Chief Medic ... | Payment of Exercise | F | 44.74 | 17,140 | 766,844 | 105,016 | 122.2 K to 105 K (-14.03 %) |
| Sep 01 2016 | FPRX | FIVE PRIME THERAPE ... | Belsky Marc | Senior Vice Preside ... | Payment of Exercise | F | 44.74 | 17,980 | 804,425 | 67,947 | 50 K to 67.9 K (+35.98 %) |
| Sep 01 2016 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | EVP, Gen Counsel an ... | Payment of Exercise | F | 44.74 | 19,568 | 875,472 | 74,266 | 93.8 K to 74.3 K (-20.85 %) |
| Sep 01 2016 | FPRX | FIVE PRIME THERAPE ... | Knickerbocker Aron Marc | EVP and Chief Busin ... | Payment of Exercise | F | 44.74 | 17,829 | 797,669 | 175,889 | 193.7 K to 175.9 K (-9.20 %) |
| Sep 01 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Gift | G | 44.74 | 22,416 | 1,002,892 | 434,299 | 456.7 K to 434.3 K (-4.91 %) |
| Sep 01 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Payment of Exercise | F | 44.74 | 7,613 | 340,606 | 456,715 | 464.3 K to 456.7 K (-1.64 %) |
| Aug 29 2016 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | EVP, Gen Counsel an ... | Option Exercise | A | 43.71 | 60,000 | 2,622,600 | 60,000 | |
| Aug 29 2016 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | EVP, Gen Counsel an ... | Grant | A | 0.00 | 10,000 | 0 | 93,834 | 83.8 K to 93.8 K (+11.93 %) |
| Aug 29 2016 | FPRX | FIVE PRIME THERAPE ... | Belsky Marc | Senior Vice Preside ... | Option Exercise | A | 43.71 | 30,000 | 1,311,300 | 30,000 | |
| Aug 29 2016 | FPRX | FIVE PRIME THERAPE ... | Belsky Marc | Senior Vice Preside ... | Grant | A | 0.00 | 5,000 | 0 | 85,927 | 80.9 K to 85.9 K (+6.18 %) |
| Aug 29 2016 | FPRX | FIVE PRIME THERAPE ... | Baker Kevin Paul | SVP, Development Sc ... | Grant | A | 0.00 | 7,500 | 0 | 82,500 | 75 K to 82.5 K (+10.00 %) |
| Aug 29 2016 | FPRX | FIVE PRIME THERAPE ... | Sikorski Robert Steven | SVP and Chief Medic ... | Option Exercise | A | 43.71 | 60,000 | 2,622,600 | 60,000 | |
| Aug 29 2016 | FPRX | FIVE PRIME THERAPE ... | Sikorski Robert Steven | SVP and Chief Medic ... | Grant | A | 0.00 | 10,000 | 0 | 122,156 | 112.2 K to 122.2 K (+8.92 %) |
| Aug 29 2016 | FPRX | FIVE PRIME THERAPE ... | Knickerbocker Aron Marc | EVP and Chief Busin ... | Option Exercise | A | 43.71 | 60,000 | 2,622,600 | 60,000 | |
| Aug 29 2016 | FPRX | FIVE PRIME THERAPE ... | Knickerbocker Aron Marc | EVP and Chief Busin ... | Grant | A | 0.00 | 10,000 | 0 | 193,718 | 183.7 K to 193.7 K (+5.44 %) |
| Aug 29 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Option Exercise | A | 43.71 | 180,000 | 7,867,800 | 180,000 | |
| Aug 29 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Grant | A | 0.00 | 42,500 | 0 | 464,328 | 421.8 K to 464.3 K (+10.08 %) |
| Aug 02 2016 | FPRX | FIVE PRIME THERAPE ... | RINGO WILLIAM R | Director | Option Exercise | S | 50.77 | 500 | 25,385 | 0 | |
| Aug 02 2016 | FPRX | FIVE PRIME THERAPE ... | RINGO WILLIAM R | Director | Sell | S | 50.77 | 500 | 25,385 | 0 | 500 to 0 (-100.00 %) |
| Aug 02 2016 | FPRX | FIVE PRIME THERAPE ... | RINGO WILLIAM R | Director | Buy | M | 11.65 | 500 | 5,825 | 500 | 0 to 500 |
| Jul 28 2016 | FPRX | FIVE PRIME THERAPE ... | Jensen Peder | Director | Option Exercise | M | 8.49 | 12,195 | 103,536 | 0 | |
| Jul 28 2016 | FPRX | FIVE PRIME THERAPE ... | Jensen Peder | Director | Sell | S | 49.50 | 12,195 | 603,653 | 0 | 12.2 K to 0 (-100.00 %) |
| Jul 28 2016 | FPRX | FIVE PRIME THERAPE ... | Jensen Peder | Director | Buy | M | 8.49 | 12,195 | 103,536 | 12,195 | 0 to 12.2 K |
| Jun 01 2016 | FPRX | FIVE PRIME THERAPE ... | Sikorski Robert Steven | SVP and Chief Medic ... | Option Exercise | A | 45.24 | 35,000 | 1,583,400 | 35,000 | |
| Jun 01 2016 | FPRX | FIVE PRIME THERAPE ... | Sikorski Robert Steven | SVP and Chief Medic ... | Grant | A | 0.00 | 10,000 | 0 | 112,156 | 102.2 K to 112.2 K (+9.79 %) |
| May 23 2016 | FPRX | FIVE PRIME THERAPE ... | RINGO WILLIAM R | Director | Option Exercise | A | 42.25 | 10,000 | 422,500 | 0 | |
| May 23 2016 | FPRX | FIVE PRIME THERAPE ... | MCDADE MARK | Director | Option Exercise | A | 42.25 | 10,000 | 422,500 | 0 | |
| May 23 2016 | FPRX | FIVE PRIME THERAPE ... | Jensen Peder | Director | Option Exercise | A | 42.25 | 10,000 | 422,500 | 0 | |
| May 23 2016 | FPRX | FIVE PRIME THERAPE ... | Gujrathi Sheila | Director | Option Exercise | A | 42.25 | 10,000 | 422,500 | 0 | |
| May 23 2016 | FPRX | FIVE PRIME THERAPE ... | Douglas R Lee | Director | Option Exercise | A | 42.25 | 10,000 | 422,500 | 0 | |
| May 23 2016 | FPRX | FIVE PRIME THERAPE ... | Dhingra Kapil | Director | Option Exercise | A | 42.25 | 10,000 | 422,500 | 0 | |
| May 23 2016 | FPRX | FIVE PRIME THERAPE ... | Cohen Fred E | Director | Option Exercise | A | 42.25 | 10,000 | 422,500 | 0 | |
| May 23 2016 | FPRX | FIVE PRIME THERAPE ... | BERGER FRANKLIN M | Director | Option Exercise | A | 42.25 | 10,000 | 422,500 | 0 | |
| May 13 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Option Exercise | M | 1.23 | 81,300 | 99,999 | 0 | |
| May 13 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Buy | M | 1.23 | 81,300 | 99,999 | 421,828 | 340.5 K to 421.8 K (+23.87 %) |
| Apr 07 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Option Exercise | M | 8.49 | 26,852 | 227,973 | 69,150 | |
| Apr 07 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Option Exercise | M | 8.49 | 25,949 | 220,307 | 96,002 | |
| Apr 07 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Sell | S | 43.17 | 26,852 | 1,159,201 | 340,528 | 367.4 K to 340.5 K (-7.31 %) |
| Apr 07 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Buy | M | 8.49 | 26,852 | 227,973 | 367,380 | 340.5 K to 367.4 K (+7.89 %) |
| Apr 07 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Sell | S | 43.00 | 25,949 | 1,115,807 | 340,528 | 366.5 K to 340.5 K (-7.08 %) |
| Apr 07 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Buy | M | 8.49 | 25,949 | 220,307 | 366,477 | 340.5 K to 366.5 K (+7.62 %) |
| Apr 26 2016 | FPRX | FIVE PRIME THERAPE ... | Belsky Marc | Senior Vice Preside ... | Option Exercise | M | 19.25 | 3,052 | 58,751 | 41,948 | |
| Apr 26 2016 | FPRX | FIVE PRIME THERAPE ... | Belsky Marc | Senior Vice Preside ... | Option Exercise | M | 11.14 | 12,389 | 138,013 | 17,611 | |
| Apr 26 2016 | FPRX | FIVE PRIME THERAPE ... | Belsky Marc | Senior Vice Preside ... | Option Exercise | M | 7.26 | 11,178 | 81,152 | 5,082 | |
| Apr 26 2016 | FPRX | FIVE PRIME THERAPE ... | Belsky Marc | Senior Vice Preside ... | Option Exercise | M | 5.54 | 7,483 | 41,456 | 509 | |
| Apr 26 2016 | FPRX | FIVE PRIME THERAPE ... | Belsky Marc | Senior Vice Preside ... | Sell | S | 50.03 | 33,002 | 1,651,090 | 80,927 | 113.9 K to 80.9 K (-28.97 %) |
| Apr 26 2016 | FPRX | FIVE PRIME THERAPE ... | Belsky Marc | Senior Vice Preside ... | Sell | S | 49.24 | 1,100 | 54,164 | 113,929 | 115 K to 113.9 K (-0.96 %) |
| Apr 26 2016 | FPRX | FIVE PRIME THERAPE ... | Belsky Marc | Senior Vice Preside ... | Buy | M | 19.25 | 3,052 | 58,751 | 115,029 | 112 K to 115 K (+2.73 %) |
| Apr 26 2016 | FPRX | FIVE PRIME THERAPE ... | Belsky Marc | Senior Vice Preside ... | Buy | M | 11.14 | 12,389 | 138,013 | 111,977 | 99.6 K to 112 K (+12.44 %) |
| Apr 26 2016 | FPRX | FIVE PRIME THERAPE ... | Belsky Marc | Senior Vice Preside ... | Buy | M | 7.26 | 11,178 | 81,152 | 99,588 | 88.4 K to 99.6 K (+12.64 %) |
| Apr 26 2016 | FPRX | FIVE PRIME THERAPE ... | Belsky Marc | Senior Vice Preside ... | Buy | M | 5.54 | 7,483 | 41,456 | 88,410 | 80.9 K to 88.4 K (+9.25 %) |
| Apr 26 2016 | FPRX | FIVE PRIME THERAPE ... | BERGER FRANKLIN M | Director | Buy | P | 49.18 | 3,000 | 147,540 | 84,980 | 82 K to 85 K (+3.66 %) |
| Apr 26 2016 | FPRX | FIVE PRIME THERAPE ... | BERGER FRANKLIN M | Director | Buy | P | 49.90 | 2,000 | 99,800 | 81,980 | 80 K to 82 K (+2.50 %) |
| Mar 31 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Option Exercise | M | 6.89 | 14,044 | 96,763 | 14,457 | |
| Mar 31 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Option Exercise | M | 6.89 | 9,215 | 63,491 | 28,501 | |
| Mar 31 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Sell | S | 40.02 | 14,044 | 562,041 | 340,528 | 354.6 K to 340.5 K (-3.96 %) |
| Mar 31 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Buy | M | 6.89 | 14,044 | 96,763 | 354,572 | 340.5 K to 354.6 K (+4.12 %) |
| Mar 31 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Sell | S | 40.01 | 9,215 | 368,692 | 340,528 | 349.7 K to 340.5 K (-2.63 %) |
| Mar 31 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Buy | M | 6.89 | 9,215 | 63,491 | 349,743 | 340.5 K to 349.7 K (+2.71 %) |
| Mar 31 2016 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | EVP, Gen Counsel an ... | Option Exercise | M | 8.49 | 5,550 | 47,120 | 4,747 | |
| Mar 31 2016 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | EVP, Gen Counsel an ... | Option Exercise | M | 8.49 | 3,524 | 29,919 | 10,297 | |
| Mar 31 2016 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | EVP, Gen Counsel an ... | Option Exercise | M | 8.49 | 926 | 7,862 | 0 | |
| Mar 31 2016 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | EVP, Gen Counsel an ... | Sell | S | 40.01 | 5,550 | 222,056 | 83,834 | 89.4 K to 83.8 K (-6.21 %) |
| Mar 31 2016 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | EVP, Gen Counsel an ... | Buy | M | 8.49 | 5,550 | 47,120 | 89,384 | 83.8 K to 89.4 K (+6.62 %) |
| Mar 31 2016 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | EVP, Gen Counsel an ... | Sell | S | 40.00 | 4,450 | 178,000 | 83,834 | 88.3 K to 83.8 K (-5.04 %) |
| Mar 31 2016 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | EVP, Gen Counsel an ... | Buy | M | 8.49 | 4,450 | 37,781 | 88,284 | 83.8 K to 88.3 K (+5.31 %) |
| Mar 31 2016 | FPRX | FIVE PRIME THERAPE ... | Belsky Marc | Senior Vice Preside ... | Option Exercise | M | 4.56 | 9,052 | 41,277 | 351 | |
| Mar 31 2016 | FPRX | FIVE PRIME THERAPE ... | Belsky Marc | Senior Vice Preside ... | Option Exercise | M | 4.56 | 4,824 | 21,997 | 9,403 | |
| Mar 31 2016 | FPRX | FIVE PRIME THERAPE ... | Belsky Marc | Senior Vice Preside ... | Sell | S | 40.01 | 9,052 | 362,171 | 80,927 | 90 K to 80.9 K (-10.06 %) |
| Mar 31 2016 | FPRX | FIVE PRIME THERAPE ... | Belsky Marc | Senior Vice Preside ... | Buy | M | 4.56 | 9,052 | 41,277 | 89,979 | 80.9 K to 90 K (+11.19 %) |
| Mar 31 2016 | FPRX | FIVE PRIME THERAPE ... | Belsky Marc | Senior Vice Preside ... | Sell | S | 40.00 | 4,824 | 192,960 | 80,927 | 85.8 K to 80.9 K (-5.63 %) |
| Mar 31 2016 | FPRX | FIVE PRIME THERAPE ... | Belsky Marc | Senior Vice Preside ... | Buy | M | 4.56 | 4,824 | 21,997 | 85,751 | 80.9 K to 85.8 K (+5.96 %) |
| Mar 17 2016 | FPRX | FIVE PRIME THERAPE ... | MCDADE MARK | Director | Option Exercise | A | 32.11 | 10,000 | 321,100 | 10,000 | |
| Mar 03 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President and CEO | Option Exercise | M | 6.89 | 23,259 | 160,255 | 37,716 | |
| Mar 03 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President and CEO | Sell | S | 36.01 | 23,259 | 837,557 | 340,352 | 363.6 K to 340.4 K (-6.40 %) |
| Mar 03 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President and CEO | Buy | M | 6.89 | 23,259 | 160,255 | 363,611 | 340.4 K to 363.6 K (+6.83 %) |
| Feb 08 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President and CEO | Option Exercise | M | 4.56 | 35,614 | 162,400 | 91,372 | |
| Feb 08 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President and CEO | Option Exercise | M | 4.56 | 35,615 | 162,404 | 126,986 | |
| Feb 08 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President and CEO | Sell | S | 35.48 | 121 | 4,293 | 340,352 | 340.5 K to 340.4 K (-0.04 %) |
| Feb 08 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President and CEO | Sell | S | 34.70 | 4,528 | 157,122 | 340,473 | 345 K to 340.5 K (-1.31 %) |
| Feb 08 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President and CEO | Sell | S | 33.76 | 12,408 | 418,894 | 345,001 | 357.4 K to 345 K (-3.47 %) |
| Feb 08 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President and CEO | Sell | S | 32.74 | 18,557 | 607,556 | 357,409 | 376 K to 357.4 K (-4.94 %) |
| Feb 08 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President and CEO | Buy | M | 4.56 | 35,614 | 162,400 | 375,966 | 340.4 K to 376 K (+10.46 %) |
| Feb 08 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President and CEO | Sell | S | 34.84 | 3,729 | 129,918 | 340,352 | 344.1 K to 340.4 K (-1.08 %) |
| Feb 08 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President and CEO | Sell | S | 33.83 | 11,800 | 399,194 | 344,081 | 355.9 K to 344.1 K (-3.32 %) |
| Feb 08 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President and CEO | Sell | S | 32.79 | 20,086 | 658,620 | 355,881 | 376 K to 355.9 K (-5.34 %) |
| Feb 08 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President and CEO | Buy | M | 4.56 | 35,615 | 162,404 | 375,967 | 340.4 K to 376 K (+10.46 %) |
| Feb 03 2016 | FPRX | FIVE PRIME THERAPE ... | Baker Kevin Paul | SVP, Development Sc ... | Option Exercise | A | 35.53 | 75,000 | 2,664,750 | 75,000 | |
| Feb 03 2016 | FPRX | FIVE PRIME THERAPE ... | Baker Kevin Paul | SVP, Development Sc ... | Grant | A | 0.00 | 75,000 | 0 | 75,000 | 0 to 75 K |
| Apr 22 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Option Exercise | M | 8.49 | 48,121 | 408,547 | 16,349 | |
| Apr 22 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Option Exercise | M | 8.49 | 550 | 4,670 | 64,470 | |
| Apr 22 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Sell | S | 48.05 | 48,121 | 2,312,214 | 340,528 | 388.6 K to 340.5 K (-12.38 %) |
| Apr 22 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Buy | M | 8.49 | 48,121 | 408,547 | 388,649 | 340.5 K to 388.6 K (+14.13 %) |
| Apr 22 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Sell | S | 48.00 | 550 | 26,400 | 340,528 | 341.1 K to 340.5 K (-0.16 %) |
| Apr 22 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Buy | M | 8.49 | 550 | 4,670 | 341,078 | 340.5 K to 341.1 K (+0.16 %) |
| Apr 21 2016 | FPRX | FIVE PRIME THERAPE ... | BERGER FRANKLIN M | Director | Buy | P | 46.74 | 2,090 | 97,687 | 79,980 | 77.9 K to 80 K (+2.68 %) |
| Apr 21 2016 | FPRX | FIVE PRIME THERAPE ... | BERGER FRANKLIN M | Director | Buy | P | 47.23 | 4,000 | 188,920 | 77,890 | 73.9 K to 77.9 K (+5.41 %) |
| Apr 18 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Option Exercise | M | 8.49 | 1,405 | 11,928 | 65,020 | |
| Apr 18 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Sell | S | 48.00 | 1,405 | 67,440 | 340,528 | 341.9 K to 340.5 K (-0.41 %) |
| Apr 18 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Buy | M | 8.49 | 1,405 | 11,928 | 341,933 | 340.5 K to 341.9 K (+0.41 %) |
| Apr 15 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Option Exercise | M | 8.49 | 2,725 | 23,135 | 66,425 | |
| Apr 15 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Sell | S | 48.00 | 2,725 | 130,800 | 340,528 | 343.3 K to 340.5 K (-0.79 %) |
| Apr 15 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Buy | M | 8.49 | 2,725 | 23,135 | 343,253 | 340.5 K to 343.3 K (+0.80 %) |
| Apr 08 2016 | FPRX | FIVE PRIME THERAPE ... | Belsky Marc | Senior Vice Preside ... | Option Exercise | M | 5.54 | 138 | 765 | 7,992 | |
| Apr 08 2016 | FPRX | FIVE PRIME THERAPE ... | Belsky Marc | Senior Vice Preside ... | Option Exercise | M | 8.49 | 8,943 | 75,926 | 0 | |
| Apr 08 2016 | FPRX | FIVE PRIME THERAPE ... | Belsky Marc | Senior Vice Preside ... | Option Exercise | M | 6.89 | 11,382 | 78,422 | 0 | |
| Apr 08 2016 | FPRX | FIVE PRIME THERAPE ... | Belsky Marc | Senior Vice Preside ... | Option Exercise | M | 4.56 | 351 | 1,601 | 0 | |
| Apr 08 2016 | FPRX | FIVE PRIME THERAPE ... | Belsky Marc | Senior Vice Preside ... | Sell | S | 45.04 | 20,814 | 937,463 | 80,927 | 101.7 K to 80.9 K (-20.46 %) |
| Apr 08 2016 | FPRX | FIVE PRIME THERAPE ... | Belsky Marc | Senior Vice Preside ... | Buy | M | 5.54 | 138 | 765 | 101,741 | 101.6 K to 101.7 K (+0.14 %) |
| Apr 08 2016 | FPRX | FIVE PRIME THERAPE ... | Belsky Marc | Senior Vice Preside ... | Buy | M | 8.49 | 8,943 | 75,926 | 101,603 | 92.7 K to 101.6 K (+9.65 %) |
| Apr 08 2016 | FPRX | FIVE PRIME THERAPE ... | Belsky Marc | Senior Vice Preside ... | Buy | M | 6.89 | 11,382 | 78,422 | 92,660 | 81.3 K to 92.7 K (+14.00 %) |
| Apr 08 2016 | FPRX | FIVE PRIME THERAPE ... | Belsky Marc | Senior Vice Preside ... | Buy | M | 4.56 | 351 | 1,601 | 81,278 | 80.9 K to 81.3 K (+0.43 %) |
| Jan 29 2016 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | EVP, Gen Counsel & ... | Option Exercise | M | 8.49 | 1,513 | 12,845 | 926 | |
| Jan 29 2016 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | EVP, Gen Counsel & ... | Option Exercise | M | 5.54 | 7,768 | 43,035 | 24,752 | |
| Jan 29 2016 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | EVP, Gen Counsel & ... | Option Exercise | M | 7.26 | 7,449 | 54,080 | 12,063 | |
| Jan 29 2016 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | EVP, Gen Counsel & ... | Option Exercise | M | 10.77 | 3,791 | 40,829 | 3,209 | |
| Jan 29 2016 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | EVP, Gen Counsel & ... | Option Exercise | M | 11.14 | 9,479 | 105,596 | 25,521 | |
| Jan 29 2016 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | EVP, Gen Counsel & ... | Sell | S | 35.00 | 1,513 | 52,955 | 83,570 | 85.1 K to 83.6 K (-1.78 %) |
| Jan 29 2016 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | EVP, Gen Counsel & ... | Buy | M | 8.49 | 1,513 | 12,845 | 85,083 | 83.6 K to 85.1 K (+1.81 %) |
| Jan 29 2016 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | EVP, Gen Counsel & ... | Sell | S | 34.73 | 7,768 | 269,783 | 83,570 | 91.3 K to 83.6 K (-8.50 %) |
| Jan 29 2016 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | EVP, Gen Counsel & ... | Buy | M | 5.54 | 7,768 | 43,035 | 91,338 | 83.6 K to 91.3 K (+9.30 %) |
| Jan 29 2016 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | EVP, Gen Counsel & ... | Sell | S | 35.11 | 7,449 | 261,534 | 83,570 | 91 K to 83.6 K (-8.18 %) |
| Jan 29 2016 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | EVP, Gen Counsel & ... | Buy | M | 7.26 | 7,449 | 54,080 | 91,019 | 83.6 K to 91 K (+8.91 %) |
| Jan 29 2016 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | EVP, Gen Counsel & ... | Sell | S | 35.31 | 3,791 | 133,860 | 83,570 | 87.4 K to 83.6 K (-4.34 %) |
| Jan 29 2016 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | EVP, Gen Counsel & ... | Buy | M | 10.77 | 3,791 | 40,829 | 87,361 | 83.6 K to 87.4 K (+4.54 %) |
| Jan 29 2016 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | EVP, Gen Counsel & ... | Sell | S | 36.13 | 2,584 | 93,360 | 83,570 | 86.2 K to 83.6 K (-3.00 %) |
| Jan 29 2016 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | EVP, Gen Counsel & ... | Sell | S | 35.55 | 6,895 | 245,117 | 86,154 | 93 K to 86.2 K (-7.41 %) |
| Jan 29 2016 | FPRX | FIVE PRIME THERAPE ... | Sarena Francis Willard | EVP, Gen Counsel & ... | Buy | M | 11.14 | 9,479 | 105,596 | 93,049 | 83.6 K to 93 K (+11.34 %) |
| Jan 13 2016 | FPRX | FIVE PRIME THERAPE ... | Cohen Fred E | Director | Option Exercise | M | 12.70 | 12,500 | 158,750 | 0 | |
| Jan 13 2016 | FPRX | FIVE PRIME THERAPE ... | Cohen Fred E | Director | Option Exercise | M | 7.26 | 4,065 | 29,512 | 0 | |
| Jan 13 2016 | FPRX | FIVE PRIME THERAPE ... | Cohen Fred E | Director | Option Exercise | M | 5.54 | 4,065 | 22,520 | 0 | |
| Jan 13 2016 | FPRX | FIVE PRIME THERAPE ... | Cohen Fred E | Director | Option Exercise | M | 8.49 | 4,065 | 34,512 | 0 | |
| Jan 13 2016 | FPRX | FIVE PRIME THERAPE ... | Cohen Fred E | Director | Buy | M | 12.70 | 12,500 | 158,750 | 24,807 | 12.3 K to 24.8 K (+101.57 %) |
| Jan 13 2016 | FPRX | FIVE PRIME THERAPE ... | Cohen Fred E | Director | Buy | M | 7.26 | 4,065 | 29,512 | 12,307 | 8.2 K to 12.3 K (+49.32 %) |
| Jan 13 2016 | FPRX | FIVE PRIME THERAPE ... | Cohen Fred E | Director | Buy | M | 5.54 | 4,065 | 22,520 | 8,242 | 4.2 K to 8.2 K (+97.32 %) |
| Jan 13 2016 | FPRX | FIVE PRIME THERAPE ... | Cohen Fred E | Director | Buy | M | 8.49 | 4,065 | 34,512 | 4,177 | 112 to 4.2 K (+3,629.46 %) |
| Dec 28 2015 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President and CEO | Gift | G | 0.00 | 953 | 0 | 340,303 | 341.3 K to 340.3 K (-0.28 %) |
| Dec 03 2015 | FPRX | FIVE PRIME THERAPE ... | Gujrathi Sheila | Director | Option Exercise | A | 37.99 | 25,000 | 949,750 | 25,000 | |
| Dec 03 2015 | FPRX | FIVE PRIME THERAPE ... | Dhingra Kapil | Director | Option Exercise | A | 37.99 | 25,000 | 949,750 | 25,000 | |
| Nov 18 2015 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President and CEO | Grant | A | 0.00 | 50,000 | 0 | 341,256 | 291.3 K to 341.3 K (+17.17 %) |
| Nov 13 2015 | FPRX | FIVE PRIME THERAPE ... | Hambleton Julie | EVP & Chief Medical ... | Option Exercise | M | 11.14 | 12,000 | 133,680 | 38,000 | |
| Nov 13 2015 | FPRX | FIVE PRIME THERAPE ... | Hambleton Julie | EVP & Chief Medical ... | Option Exercise | M | 7.26 | 10,000 | 72,600 | 14,390 | |
| Nov 13 2015 | FPRX | FIVE PRIME THERAPE ... | Hambleton Julie | EVP & Chief Medical ... | Sell | S | 35.33 | 1,108 | 39,146 | 84,811 | 85.9 K to 84.8 K (-1.29 %) |
| Nov 13 2015 | FPRX | FIVE PRIME THERAPE ... | Hambleton Julie | EVP & Chief Medical ... | Sell | S | 34.33 | 12,000 | 411,960 | 85,919 | 97.9 K to 85.9 K (-12.26 %) |
| Nov 13 2015 | FPRX | FIVE PRIME THERAPE ... | Hambleton Julie | EVP & Chief Medical ... | Buy | M | 11.14 | 12,000 | 133,680 | 97,919 | 85.9 K to 97.9 K (+13.97 %) |
| Nov 13 2015 | FPRX | FIVE PRIME THERAPE ... | Hambleton Julie | EVP & Chief Medical ... | Sell | S | 35.23 | 3,400 | 119,782 | 85,919 | 89.3 K to 85.9 K (-3.81 %) |